CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P01592-1 GLY 000330 (Collection)

Taxon:

Mus musculus

Taxonomy (Entity type)
Ptm:

p01592-1 70asn 70asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)
Protein:

IGJ MOUSE

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

mouse proteoform glycosylation sites glyconnect.csv

File (Entity type)
Anatomy:

blood serum

Anatomy (Entity type)
Description:Information for protein P01592-1 in the context of file GLY_000330
Creation Time:2026-03-02 20:00:31.000000
Results found

Linked to

 

Label

Description

 

File

mouse proteoform glycosylation sites glyconnect.csv

File (Entity type)

A 2.06 MB file from GlyGen as part of the Portal project

Anatomy

blood serum

Anatomy (Entity type)

The portion of blood plasma that excludes clotting factors.

Compound

G15569GG

Compound (Entity type)

type="Composition" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False...

Compound

G15488CF

Compound (Entity type)

type="Composition" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False...

Compound

G40608DF

Compound (Entity type)

type="Saccharide" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False"...

Compound

G39397SW

Compound (Entity type)

type="Saccharide" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False"...

Post Translational Modification

p01592-1 70asn 70asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Protein

IGJ MOUSE

Protein (Entity type)

Immunoglobulin J chain (precursor)

  • File

    mouse proteoform glycosylation sites glyconnect.csv

    File (Entity type)

    A 2.06 MB file from GlyGen as part of the Portal project

  • Anatomy

    blood serum

    Anatomy (Entity type)

    The portion of blood plasma that excludes clotting factors.

  • Compound

    G15569GG

    Compound (Entity type)

    type="Composition" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False...

  • Compound

    G15488CF

    Compound (Entity type)

    type="Composition" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False...

  • Compound

    G40608DF

    Compound (Entity type)

    type="Saccharide" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False"...

  • Compound

    G39397SW

    Compound (Entity type)

    type="Saccharide" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False"...

  • Post Translational Modification

    p01592-1 70asn 70asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Protein

    IGJ MOUSE

    Protein (Entity type)

    Immunoglobulin J chain (precursor)

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.